US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist

3.1000
+0.1483+5.02%

Close Nov 22 16:00 ET

27.66MMarket Cap-2844P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-25.01%2.4M

-44.17%2.31M

-40.85%2.55M

-26.32%14.58M

-3.32%2.94M

-45.08%3.2M

-21.53%4.13M

-56.00%4.31M

-49.87%19.79M

-68.88%3.04M

Selling and administrative expenses

-39.50%854.68K

-54.66%1.14M

-43.80%1.22M

-34.05%7.48M

-14.76%1.38M

-56.32%1.41M

-19.66%2.52M

-41.94%2.17M

-12.29%11.34M

-45.94%1.62M

-General and administrative expense

-39.50%854.68K

-54.66%1.14M

-43.80%1.22M

-34.05%7.48M

-14.76%1.38M

-56.32%1.41M

-19.66%2.52M

-41.94%2.17M

-12.29%11.34M

-45.94%1.62M

Research and development costs

69.74%3.47M

-1.79%2.34M

-23.74%2.58M

-12.96%10.42M

19.93%2.62M

-43.07%2.04M

-18.67%2.38M

-51.94%3.38M

-56.94%11.97M

-72.78%2.18M

Other operating expenses

-647.66%-1.93M

-53.31%-1.17M

-0.79%-1.24M

5.76%-3.31M

-39.17%-1.06M

74.23%-257.61K

3.52%-762.66K

-28.00%-1.23M

-182.96%-3.51M

---759.14K

Operating profit

25.01%-2.4M

44.17%-2.31M

40.85%-2.55M

26.32%-14.58M

3.32%-2.94M

45.08%-3.2M

21.53%-4.13M

56.00%-4.31M

49.87%-19.79M

68.88%-3.04M

Net non-operating interest income expense

-57.96%91.68K

228.93%115.39K

84.51%156.2K

117.35%539.16K

84.02%201.34K

118.63%218.09K

-1.97%35.08K

2,615.88%84.65K

4,251.98%248.06K

11,191.02%109.41K

Non-operating interest income

-57.96%91.68K

228.93%115.39K

84.51%156.2K

117.35%539.16K

84.02%201.34K

118.63%218.09K

-1.97%35.08K

2,615.88%84.65K

4,251.98%248.06K

11,191.02%109.41K

Other net income (expense)

90.32%-232.97K

-114.09K

Other non- operating income (expenses)

----

90.32%-232.97K

---114.09K

Income before tax

22.59%-2.31M

46.51%-2.19M

43.36%-2.39M

28.99%-14.04M

10.08%-2.74M

47.93%-2.98M

21.67%-4.1M

57.37%-4.22M

52.78%-19.78M

68.83%-3.04M

Income tax

3.68K

Net income

22.59%-2.31M

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

Net income continuous Operations

22.59%-2.31M

46.51%-2.19M

43.36%-2.39M

28.97%-14.05M

9.96%-2.74M

47.93%-2.98M

21.67%-4.1M

57.37%-4.22M

52.78%-19.78M

68.83%-3.04M

Net income discontinuous operations

--0

157.21%5.81M

92.26%-62.94K

--0

264.90%6.61M

---742.75K

---10.15M

---813.06K

Minority interest income

Net income attributable to the parent company

22.59%-2.31M

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

22.59%-2.31M

-187.16%-2.19M

51.83%-2.39M

72.48%-8.24M

27.31%-2.8M

56.91%-2.98M

127.21%2.52M

49.88%-4.97M

28.53%-29.93M

60.50%-3.86M

Basic earnings per share

23.53%-0.26

-186.21%-0.25

52.63%-0.27

73.74%-0.94

28.89%-0.32

59.04%-0.34

126.13%0.29

52.10%-0.57

34.55%-3.58

61.54%-0.45

Diluted earnings per share

23.53%-0.26

-186.21%-0.25

52.63%-0.27

73.74%-0.94

28.89%-0.32

59.04%-0.34

126.13%0.29

52.10%-0.57

34.55%-3.58

61.54%-0.45

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-25.01%2.4M	-44.17%2.31M	-40.85%2.55M	-26.32%14.58M	-3.32%2.94M	-45.08%3.2M	-21.53%4.13M	-56.00%4.31M	-49.87%19.79M	-68.88%3.04M
Selling and administrative expenses	-39.50%854.68K	-54.66%1.14M	-43.80%1.22M	-34.05%7.48M	-14.76%1.38M	-56.32%1.41M	-19.66%2.52M	-41.94%2.17M	-12.29%11.34M	-45.94%1.62M
-General and administrative expense	-39.50%854.68K	-54.66%1.14M	-43.80%1.22M	-34.05%7.48M	-14.76%1.38M	-56.32%1.41M	-19.66%2.52M	-41.94%2.17M	-12.29%11.34M	-45.94%1.62M
Research and development costs	69.74%3.47M	-1.79%2.34M	-23.74%2.58M	-12.96%10.42M	19.93%2.62M	-43.07%2.04M	-18.67%2.38M	-51.94%3.38M	-56.94%11.97M	-72.78%2.18M
Other operating expenses	-647.66%-1.93M	-53.31%-1.17M	-0.79%-1.24M	5.76%-3.31M	-39.17%-1.06M	74.23%-257.61K	3.52%-762.66K	-28.00%-1.23M	-182.96%-3.51M	---759.14K
Operating profit	25.01%-2.4M	44.17%-2.31M	40.85%-2.55M	26.32%-14.58M	3.32%-2.94M	45.08%-3.2M	21.53%-4.13M	56.00%-4.31M	49.87%-19.79M	68.88%-3.04M
Net non-operating interest income expense	-57.96%91.68K	228.93%115.39K	84.51%156.2K	117.35%539.16K	84.02%201.34K	118.63%218.09K	-1.97%35.08K	2,615.88%84.65K	4,251.98%248.06K	11,191.02%109.41K
Non-operating interest income	-57.96%91.68K	228.93%115.39K	84.51%156.2K	117.35%539.16K	84.02%201.34K	118.63%218.09K	-1.97%35.08K	2,615.88%84.65K	4,251.98%248.06K	11,191.02%109.41K
Other net income (expense)									90.32%-232.97K	-114.09K
Other non- operating income (expenses)	----	----	----	----	----	----	----	----	90.32%-232.97K	---114.09K
Income before tax	22.59%-2.31M	46.51%-2.19M	43.36%-2.39M	28.99%-14.04M	10.08%-2.74M	47.93%-2.98M	21.67%-4.1M	57.37%-4.22M	52.78%-19.78M	68.83%-3.04M
Income tax				3.68K					0
Net income	22.59%-2.31M	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M
Net income continuous Operations	22.59%-2.31M	46.51%-2.19M	43.36%-2.39M	28.97%-14.05M	9.96%-2.74M	47.93%-2.98M	21.67%-4.1M	57.37%-4.22M	52.78%-19.78M	68.83%-3.04M
Net income discontinuous operations	--0	--0	--0	157.21%5.81M	92.26%-62.94K	--0	264.90%6.61M	---742.75K	---10.15M	---813.06K
Minority interest income
Net income attributable to the parent company	22.59%-2.31M	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	22.59%-2.31M	-187.16%-2.19M	51.83%-2.39M	72.48%-8.24M	27.31%-2.8M	56.91%-2.98M	127.21%2.52M	49.88%-4.97M	28.53%-29.93M	60.50%-3.86M
Basic earnings per share	23.53%-0.26	-186.21%-0.25	52.63%-0.27	73.74%-0.94	28.89%-0.32	59.04%-0.34	126.13%0.29	52.10%-0.57	34.55%-3.58	61.54%-0.45
Diluted earnings per share	23.53%-0.26	-186.21%-0.25	52.63%-0.27	73.74%-0.94	28.89%-0.32	59.04%-0.34	126.13%0.29	52.10%-0.57	34.55%-3.58	61.54%-0.45
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data